Evolent Health (EVH) Loans and Notes Receivables (2017 - 2018)
Evolent Health's quarterly Loans and Notes Receivables came in at $6.0 million in Q3 2018, down 50.0% quarter-over-quarter from $12.0 million in Q2 2018.
Evolent Health has reported Loans and Notes Receivables for 2 years, with the latest figure at $6.0 million in Q3 2018.
- For the quarter ending Q3 2018, Loans and Notes Receivables changed N/A year-over-year to $6.0 million; the trailing twelve-month figure through Sep 2018 stood at $6.0 million (changed N/A YoY), and the FY2017 full-year result was $20.0 million, changed N/A from the prior year.
- Loans and Notes Receivables for Q3 2018 stood at $6.0 million, down from $12.0 million in the prior quarter.
- The five-year high for Loans and Notes Receivables was $20.0 million in Q4 2017, with the low at $6.0 million in Q3 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Loans & Notes Receiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Evolent Health | 467.76 Mn | 301.79 Mn | 83.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 6.00 Mn |
| Jun 30, 2018 | 12.00 Mn |
| Mar 31, 2018 | 16.00 Mn |
| Dec 31, 2017 | 20.00 Mn |